Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.
Conditions
- Brain Metastasis
- Oligoprogression
Interventions
- RADIATION: Hypofractionated SRT (stereotactic radiotherapy)
- RADIATION: Historical single-dose SRS (stereotactic radiosurgery)
Sponsor
Centre Francois Baclesse
Collaborators